<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34373540</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>09</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>More than 50 long-term effects of COVID-19: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>16144</StartPage><MedlinePgn>16144</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">16144</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-95565-8</ELocationID><Abstract><AbstractText>COVID-19 can involve persistence, sequelae, and other medical complications that last weeks to months after initial recovery. This systematic review and meta-analysis aims to identify studies assessing the long-term effects of COVID-19. LitCOVID and Embase were searched to identify articles with original data published before the 1st of January 2021, with a minimum of 100 patients. For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. PRISMA guidelines were followed. A total of 18,251 publications were identified, of which 15 met the inclusion criteria. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included (age 17-87&#xa0;years). The included studies defined long-COVID as ranging from 14 to 110&#xa0;days post-viral infection. It was estimated that 80% of the infected patients with SARS-CoV-2 developed one or more long-term symptoms. The five most common symptoms were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). Multi-disciplinary teams are crucial to developing preventive measures, rehabilitation techniques, and clinical management strategies with whole-patient perspectives designed to address long COVID-19 care.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lopez-Leon</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7504-3441</Identifier><AffiliationInfo><Affiliation>Drug Development, Novartis Pharmaceuticals, Florham Park, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wegman-Ostrosky</LastName><ForeName>Talia</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3207-6697</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Cancerolog&#xed;a, Subdirecci&#xf3;n de Investigaci&#xf3;n B&#xe1;sica, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perelman</LastName><ForeName>Carol</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0111-1154</Identifier><AffiliationInfo><Affiliation>National Autonomous University of Mexico, SOMEDICyT, RedMPC, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sepulveda</LastName><ForeName>Rosalinda</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1146-9552</Identifier><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebolledo</LastName><ForeName>Paulina A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-9808-063X</Identifier><AffiliationInfo><Affiliation>Divison of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuapio</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9451-1914</Identifier><AffiliationInfo><Affiliation>Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villapol</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6174-4113</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Center for Neuroregeneration, Houston Methodist Research Institute, 6670 Bertnet Avenue, Houston, TX, 77030, USA. svillapol@houstonmethodist.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience in Neurological Surgery, Weill Cornell Medical College, New York, USA. svillapol@houstonmethodist.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS106640</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2021 Jan 30:2021.01.27.21250617. doi: 10.1101/2021.01.27.21250617</RefSource><PMID Version="1">33532785</PMID></CommentsCorrections><CommentsCorrections RefType="UpdateOf"><RefSource>Res Sq. 2021 Mar 01:rs.3.rs-266574. doi: 10.21203/rs.3.rs-266574/v1</RefSource><PMID Version="1">33688642</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Intern Med. 2022 Jan;175(1):JC10. doi: 10.7326/J21-0007</RefSource><PMID Version="1">34978852</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000505" MajorTopicYN="N">Alopecia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="N">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors are solely responsible for all content, and funders played no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript. S.L.L. is an employee of Novartis Pharmaceutical Company; the statements presented in the paper do not necessarily represent the position of the company. The remaining authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34373540</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-95565-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ritchie, H., Ortiz-Ospina, E., Beltekian, D., Mathieu, E., Hasell, J., Macdonald, B., Giattino, C., Appel, C., Rod&#xe9;s-Guirao, L., &amp; Roser, M. Coronavirus Pandemic (COVID-19). (2021).</Citation></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 "long haulers" stump experts. JAMA. 2020;324:1381&#x2013;1383. doi: 10.1001/jama.2020.17709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March-June 2020. Morb. Mortal Wkly Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, et al. Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann. Am. Thorac. Soc. 2021 doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against C-P-ACSG. Post-COVID-19 global health strategies: The need for an interdisciplinary approach. Aging Clin. Exp. Res. 2020;32:1613&#x2013;1620. doi: 10.1007/s40520-020-01616-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01616-x</ArticleId><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Allot A, Lu Z. LitCovid: An open database of COVID-19 literature. Nucleic Acids Res. 2021;49:D1534&#x2013;D1540. doi: 10.1093/nar/gkaa952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa952</ArticleId><ArticleId IdType="pmc">PMC7778958</ArticleId><ArticleId IdType="pubmed">33166392</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ. 2015;350:g7647. doi: 10.1136/bmj.g7647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J. Epidemiol. Community Health. 2013;67:974&#x2013;978. doi: 10.1136/jech-2013-203104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2013-203104</ArticleId><ArticleId IdType="pubmed">23963506</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews PJ, et al. Olfactory and taste dysfunction among mild-to-moderate symptomatic COVID-19 positive health care workers: An international survey. Laryngosc. Investig. Otolaryngol. 2020;5:1019&#x2013;1028. doi: 10.1002/lio2.507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lio2.507</ArticleId><ArticleId IdType="pmc">PMC7752034</ArticleId><ArticleId IdType="pubmed">33365393</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2020 doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2020 doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvan-Tejada CE, et al. Persistence of COVID-19 symptoms after recovery in mexican population. Int. J. Environ. Res. Public Health. 2020 doi: 10.3390/ijerph17249367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17249367</ArticleId><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath L, et al. Smell and taste loss in COVID-19 patients: Assessment outcomes in a Victorian population. Acta Otolaryngol. 2020 doi: 10.1080/00016489.2020.1855366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016489.2020.1855366</ArticleId><ArticleId IdType="pubmed">33307905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2020 doi: 10.1111/ijcp.13746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, et al. 'Long-COVID': A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2020 doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro KJ, Uus K, Almufarrij I, Chaudhuri N, Yioe V. Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases. Int. J. Audiol. 2020;59:889&#x2013;890. doi: 10.1080/14992027.2020.1798519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14992027.2020.1798519</ArticleId><ArticleId IdType="pubmed">32735466</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: A prospective observational cohort study. Respir. Res. 2020;21:276. doi: 10.1186/s12931-020-01546-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01546-2</ArticleId><ArticleId IdType="pmc">PMC7575703</ArticleId><ArticleId IdType="pubmed">33087116</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2020 doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS&#xa0;One. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. Track COVID-19 sickness, not just positive tests and deaths. Nature. 2020;584:170. doi: 10.1038/d41586-020-02335-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02335-z</ArticleId><ArticleId IdType="pubmed">32782377</ArticleId></ArticleIdList></Reference><Reference><Citation>Neufeld KJ, et al. Fatigue symptoms during the first year following ARDS. Chest. 2020;158:999&#x2013;1007. doi: 10.1016/j.chest.2020.03.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.03.059</ArticleId><ArticleId IdType="pmc">PMC7478232</ArticleId><ArticleId IdType="pubmed">32304774</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med. Hypotheses. 2021;146:110469. doi: 10.1016/j.mehy.2020.110469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110469</ArticleId><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M, Vink-Niese A. Could cognitive behavioural therapy be an effective treatment for long COVID and post COVID-19 fatigue syndrome? lessons from the Qure study for Q-fever fatigue syndrome. Healthcare (Basel) 2020 doi: 10.3390/healthcare8040552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8040552</ArticleId><ArticleId IdType="pmc">PMC7764131</ArticleId><ArticleId IdType="pubmed">33322316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamprecht B. Is there a post-COVID syndrome? Pneumologe (Berl) 2020 doi: 10.1007/s10405-020-00347-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10405-020-00347-0</ArticleId><ArticleId IdType="pmc">PMC7543035</ArticleId><ArticleId IdType="pubmed">33052198</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallanti S, Grassi E, Makris N, Gasic GP, Hollander E. Neurocovid-19: A clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae. J. Psychiatr. Res. 2020;130:215&#x2013;217. doi: 10.1016/j.jpsychires.2020.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.08.008</ArticleId><ArticleId IdType="pmc">PMC7428715</ArticleId><ArticleId IdType="pubmed">32836010</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Long-haul COVID. Neurology. 2020;95:559&#x2013;560. doi: 10.1212/WNL.0000000000010640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010640</ArticleId><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness Mil. Med. 2015;180:721&#x2013;723. doi: 10.7205/MILMED-D-15-00085.</Citation><ArticleIdList><ArticleId IdType="doi">10.7205/MILMED-D-15-00085</ArticleId><ArticleId IdType="pubmed">26126237</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A, Marshall T. Myalgic encephalomyelitis/chronic fatigue syndrome in the era of the human microbiome: Persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity. Front. Pediatr. 2018;6:373. doi: 10.3389/fped.2018.00373.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00373</ArticleId><ArticleId IdType="pmc">PMC6288442</ArticleId><ArticleId IdType="pubmed">30564562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T, et al. Finding the &#x2018;right&#x2019; GP: A qualitative study of the experiences of people with long-COVID. BJGP Open. 2020 doi: 10.3399/bjgpopen20X101143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev. Neurol. (Paris) 2020 doi: 10.1016/j.neurol.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldini T, et al. Cerebral venous thrombosis and SARS-CoV-2 infection: A systematic review and meta-analysis. Eur. J. Neurol. 2021 doi: 10.1111/ene.14727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14727</ArticleId><ArticleId IdType="pmc">PMC8014715</ArticleId><ArticleId IdType="pubmed">33426733</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacaro V, et al. Insomnia in the Italian population during Covid-19 outbreak: A snapshot on one major risk factor for depression and anxiety. Front. Psychiatry. 2020;11:579107. doi: 10.3389/fpsyt.2020.579107.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.579107</ArticleId><ArticleId IdType="pmc">PMC7769843</ArticleId><ArticleId IdType="pubmed">33384625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mieczkowska K, et al. Telogen effluvium: A sequela of COVID-19. Int. J. Dermatol. 2021;60:122&#x2013;124. doi: 10.1111/ijd.15313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.15313</ArticleId><ArticleId IdType="pmc">PMC7753411</ArticleId><ArticleId IdType="pubmed">33226117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng CK, et al. Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors. Thorax. 2004;59:889&#x2013;891. doi: 10.1136/thx.2004.023762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.023762</ArticleId><ArticleId IdType="pmc">PMC1746851</ArticleId><ArticleId IdType="pubmed">15454656</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhang Z, Shi Y, Jiang Y. Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: Radiologic findings. Radiology. 2013;268:882&#x2013;889. doi: 10.1148/radiol.13130988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.13130988</ArticleId><ArticleId IdType="pubmed">23821754</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir. Res. 2020;21:163. doi: 10.1186/s12931-020-01429-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01429-6</ArticleId><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401&#x2013;409. doi: 10.1136/thx.2004.030205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.030205</ArticleId><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: What decides the outcome? Nat. Rev. Immunol. 2010;10:514&#x2013;526. doi: 10.1038/nri2802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2802</ArticleId><ArticleId IdType="pmc">PMC3899649</ArticleId><ArticleId IdType="pubmed">20577268</ArticleId></ArticleIdList></Reference><Reference><Citation>Goertz YMJ, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020 doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368:473&#x2013;474. doi: 10.1126/science.abb8925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai JC, et al. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15:543&#x2013;550. doi: 10.1111/j.1440-1843.2010.01720.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2010.01720.x</ArticleId><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Suliman YA, et al. Brief report: Pulmonary function tests: High rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol. 2015;67:3256&#x2013;3261. doi: 10.1002/art.39405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39405</ArticleId><ArticleId IdType="pubmed">26316389</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C, Malani PN. COVID-19-new insights on a rapidly changing epidemic. JAMA. 2020;323:1339&#x2013;1340. doi: 10.1001/jama.2020.3072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3072</ArticleId><ArticleId IdType="pubmed">32108857</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L, Benton M, Torres-Harding S, Muldowney K. The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFS. Patient Educ. Couns. 2009;77:237&#x2013;241. doi: 10.1016/j.pec.2009.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2009.02.015</ArticleId><ArticleId IdType="pmc">PMC2767446</ArticleId><ArticleId IdType="pubmed">19356884</ArticleId></ArticleIdList></Reference><Reference><Citation>White PD, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): A randomised trial. Lancet. 2011;377:823&#x2013;836. doi: 10.1016/S0140-6736(11)60096-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60096-2</ArticleId><ArticleId IdType="pmc">PMC3065633</ArticleId><ArticleId IdType="pubmed">21334061</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>